Organ distribution of thallium-201 during intravenous adenosine infusion: comparison with exercise

Quantitative assessment of myocardial 99mTc-sestamibi uptake during exercise: usefulness of response rate for assessing severity of coronary artery disease

An increase of 99mTc-sestamibi uptake in the myocardium during exercise was defined as a response rate, and the feasibility of a response rate for detecting coronary artery disease (CAD) was tested. Eighty-seven patients with suspected CAD had myocardial perfusion imaging with 99mTc-sestamibi during exercise and at rest. A dose of 370 MBq of 99mTc-sestamibi was injected at the maximal level of exercise, and a myocardial image was obtained 90 min later (exercise image). Then, 740 MBq of 99mTc-sestamibi was administered at rest, and myocardial imaging was repeated (rest image). The exercise and rest images were corrected for physical decay and injected doses, and the exercise image was subtracted from the rest image to obtain the corrected rest image. A response rate was calculated as follows: (exercise image-corrected rest image)x100/corrected rest image (%). The global response rates of 20 patients without significant coronary stenosis (< or =50%) were higher than those of 67 patients with significant coronary stenosis (81+/-33% and 50+/-28%, p<0.01). Global response rates were correlated with the maximal rate pressure products during exercise (r=0.56, p<0.01) and delta rate pressure products (r=0.53, p<0.01). Regional response rates in myocardial areas perfused by stenotic coronary arteries of < or =50%, 75%, 90% and 99-100% were 60+/-24%,* 56+/-33%,* 40+/-23%* and 30+/-23%,* respectively, (*p<0.01 vs without significant coronary stenosis). The response rates decreased as the severity of coronary artery stenosis advanced, and distinguished between coronary stenoses of graded severity. Accordingly, the response rate from myocardial perfusion imaging with 99mTc-sestamibi may provide complementary information to the conventional inspection with myocardial tomography regarding the severity of CAD.

Influence of patient height and weight and type of stress on myocardial count density during SPECT imaging with thallium-201 and technetium 99m-sestamibi

BACKGROUND

The aim of this study was to determine the variability in myocardial activity with 99mTc-labeled sestamibi and 201Tl tomographic imaging, and to correlate this variability with patient anthropometric data and type of stress.

METHODS AND RESULTS

Conventional tomographic acquisition (all-purpose collimator, 30 views, 40 sec/view) was performed in 249 patients (155 with 99mTc-sestamibi, 84 with 201Tl). Normal myocardium was identified in three short-axis tomographic slices between the base and mid-ventricle. To exclude abnormal myocardium, all myocardial activity below an 85% threshold of peak counts was excluded. The average counts per pixel in the remaining myocardium was determined. All data were normalized to a collimator sensitivity of 8.1 counts/min/kBq and corrected for decay. Myocardial count densities in both 201Tl and 99mTc-sestamibi studies exhibited a high degree of variability and varied by factors of 3 to 4 and 2.5 to 3 respectively, between the 10th and 90th percentile of count densities. All 99mTc-sestamibi studies showed an inverse correlation (R approximately 0.7) between myocardial count density and patient weight. For stress 201Tl studies in male patients, a similar inverse correlation (R = 0.63) was found between patient weight and myocardial count density. No correlation was found for female patients. For rest 99mTc-sestamibi studies, the average myocardial count density was 1245 +/- 297 counts/pixel for a 1.11 GBq (30 mCi) injection. This was similar with pharmacologic stress (1224 +/- 297 counts/pixel per 1.11 GBq (30 mCi), but significantly higher with exercise (1569 +/- 363 counts/pixel per 1.11 GBq (30 mCi) (p < 0.005). 201Tl studies averaged 327 +/- 97 counts/pixel (111 MBq [3 mCi] injection) with exercise and 374 +/- 145 counts/pixel/111 MBq (3 mCi) with pharmacologic stress (p = NS). Redistribution studies after exercise/pharmacologic stress (with a 37 MBq [1 mCi] reinjection) averaged 267 +/- 83 counts/pixel (148 MBq [3+1 mCi]).

CONCLUSIONS

Measured count densities in the myocardium demonstrate a high degree of variability that is only weakly correlated with patient anthropometric data. Nevertheless, knowledge of the mean values of myocardial activity as a function of administered dose may be useful in the optimization of rapid imaging procedures for 99mTc-based perfusion agents.

Impaired myocardial fatty acid metabolism detected by 123I-BMIPP in patients with unstable angina pectoris: comparison with perfusion imaging by 99mTc-sestamibi

The present study was undertaken to determine the potential diagnostic value of 123I-BMIPP scintigraphy for the detection of altered myocardial fatty acid metabolism in patients with unstable angina. Both myocardial metabolic imaging with 123I-BMIPP and perfusion imaging with 99mTc-sestamibi were performed at rest in 28 patients with unstable angina in the pain-free state. The regional uptakes of 123I-BMIPP or 99mTc-sestamibi were scored semiquantitatively (0 = normal, 4 = no activity) and compared with the coronary arteriographic findings. Decreased uptakes of 123I-BMIPP were observed in 18 patients, and 11 patients had abnormal 99mTc-sestamibi images. Defect scores of 123I-BMIPP were larger than those of 99mTc-sestamibi (7.8 +/- 2.1 vs. 5.2 +/- 1.9, p < 0.01). The sensitivity for the detection of patients with unstable angina was higher in 123I-BMIPP than in 99mTc-sestamibi (77% vs. 45%, p < 0.01). The site of the decreased 123I-BMIPP uptake corresponded to the most stenotic coronary artery lesion in all patients. Fatty acid metabolic imaging with 123I-BMIPP was more sensitive for detecting myocardial ischemia than perfusion imaging with 99mTc-sestamibi. 123I-BMIPP may be a clue to define the culprit lesion in unstable angina and be helpful to decide the best treatment and guide coronary angioplasty.